Danvers cardiac device maker gets the nod from the federal Food & Drug Administration for its latest heart pumps to hit the market.
Abiomed Inc.'s latest heart pump models got the nod to hit the market from the federal Food & Drug Administration.
The federal watchdog agency granted 510(k) approval for the Danvers-based heart pump maker's Impella 5.0 and Impella LD devices.
That means the minimally-invasive catheter-based pumps are cleared to provide circulatory support for up to six hours, easing the burden on patients' hearts during serious cardiac events.
Case Western Reserve University medical student raises $100,000 for emergency airway access device...
ArtVentive Medical Group Inc. inks an agreement with Northwest Clinical Research Group Inc. designed...
New MedVentive chief growth officer Nancy Brown to head the company's sales, marketing and...
Ohio business and elected leaders challenge a political TV ad from Gov. Ted Strickland that they say...
Varian Medical Systems Inc. establishes its first training center in India.